Heran Partners

What is Heran Partners?

Heran Partners is a venture capital firm based in Antwerp, Belgium that is dedicated to fueling the growth of the next generation of HealthTech ventures. They specialize in investing in life science sectors, with a particular focus on medtech hardware and healthtech companies.

Their approach to investment is built upon guiding principles that prioritize innovation, potential impact in healthcare, and sustainability. Heran Partners actively seeks startups that are pushing the boundaries in health technology, offering strategic capital investment as well as expertise to nurture their growth and development. They work closely with the founding teams to shape the trajectory of their portfolio companies, ensuring alignment with their investment thesis.

Heran Partners is involved in managing HealthTech Fund I, which supports emerging companies in the healthcare technology landscape. They process a multitude of pitches meticulously and consider novel investment opportunities, constantly planning for the next funds and investment strategies. The firm's activities extend to facilitating FDA clearances and knowledge discovery platforms, as evidenced by their announcements regarding icobrain aria's FDA clearance and the release of DISQOVER 7.

Moreover, their recent strategic move includes the acquisition of Thirona's retina business unit by Revenio Group. Committed to legal compliance and community engagement, Heran Partners invites individuals and companies to submit pitches, join their investment funds, and receive updates on events and news through their newsletter subscriptions. Their team is composed of individuals with varied expertise who are open to discussing new investment propositions with potential partners and stakeholders in the industry.